Lipella Pharmaceuticals Inc. (LIPO)
LIPO Stock Price Chart
Explore Lipella Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze LIPO price movements and trends.
LIPO Company Profile
Discover essential business fundamentals and corporate details for Lipella Pharmaceuticals Inc. (LIPO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Dec 2022
Employees
5.00
Website
https://www.lipella.comCEO
Jonathan Kaufman
Description
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.
LIPO Financial Timeline
Browse a chronological timeline of Lipella Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$0.31 , while revenue for the quarter reached $86.73M .
Earnings released on 14 May 2025
EPS came in at -$0.64 , while revenue for the quarter reached $129.39M .
Earnings released on 27 Mar 2025
EPS came in at -$1.19 surpassing the estimated -$2.43 by +51.03%, while revenue for the quarter reached $173.67K .
Earnings released on 14 Nov 2024
EPS came in at -$1.29 falling short of the estimated -$0.96 by -34.38%, while revenue for the quarter reached $80.38K , beating expectations by +0.48%.
Stock split effective on 8 Nov 2024
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Aug 2024
EPS came in at -$0.96 matching the estimated -$0.96, while revenue for the quarter reached $136.00K , meeting expectations.
Earnings released on 9 May 2024
EPS came in at -$1.28 matching the estimated -$1.28, while revenue for the quarter reached $146.00K , meeting expectations.
Earnings released on 27 Feb 2024
EPS came in at -$0.72 , while revenue for the quarter reached $120.84K .
Earnings released on 13 Nov 2023
EPS came in at -$1.84 , while revenue for the quarter reached $104.05M .
Earnings released on 14 Aug 2023
EPS came in at -$2.16 , while revenue for the quarter reached $106.68M .
Earnings released on 30 Jun 2023
EPS came in at -$1.49 .
Earnings released on 15 May 2023
EPS came in at -$1.52 , while revenue for the quarter reached $151.01K .
Earnings released on 30 Sept 2022
EPS came in at -$1.39 .
Earnings released on 30 Jun 2022
EPS came in at -$1.62 .
Earnings released on 31 Mar 2022
EPS came in at -$1.53 , while revenue for the quarter reached $33.15K .
Earnings released on 31 Dec 2021
EPS came in at -$0.79 , while revenue for the quarter reached $25.88K .
Earnings released on 30 Sept 2021
EPS came in at -$1.09 .
Earnings released on 30 Jun 2021
EPS came in at -$0.80 , while revenue for the quarter reached $148.97K .
Earnings released on 31 Mar 2021
EPS came in at -$1.95 , while revenue for the quarter reached $84.50K .
LIPO Stock Performance
Access detailed LIPO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.